Maja Mitrašinović-Brulić

Maja Mitrašinović-Brulić

Auto-generated profile, based on publicly available information

Maja Mitrašinović-Brulić

Faculty of Science, Department of Biology, University of Sarajevo, Sarajevo, Bosnia and Herzegovina

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2021 in Middle East Fertility Society Journal
Verified
Journal Article
Open access
PDF file
MMMaja Mitrašinović-Brulić
Maja Mitrašinović-Brulić
MBMihaela Buljan
Mihaela Buljan
DSDamir Suljević
Damir Suljević
Background: Understanding the global prevalence and phenotypic features of polycystic ovary syndrome (PCOS) is important as geographic factors and ethnic variations can significantly alter the clinical syndrome. The aim of this study was to determine and evaluate the luteinizing hormone/follicle-stimulating hormone ratio (LH/FSH) in women with PCOS during therapy on selected endocrine and biochemical parameters. Results: Women with PCOS were included in the study and were classified into two groups: women without therapy (de novo) and women with therapy for PCOS. ESHERE/ASRM criteria that require the presence of two out of three criteria: ovulatory dysfunction, hyperandrogenism, and morphological PCOS detected by ultrasound diagnostics. Electrochemiluminescence immunoassay (ECLIA) was used for FSH and insulin analysis. The enzymatic method was used to analyze the biochemical profile. There was a significant difference between the two groups in terms of the LH/FSH ratio (2.56 vs. 2.41, P=0.043), glucose (6.23 vs. 5.12, P=0.003), insulin (19.21 vs. 7.35, P=0.000), IR (3.22 vs. 1.42, P=0.000), cholesterol (5.97 vs. 4.92, P=0.002), and LDL (3.56 vs. 2.56, P=0.001). The data suggest that patients with PCOS therapy have reduced hyperinsulinemia and insulin resistance. There was a significant correlation between the LH and FSH in the de novo group, as well as the correlation between hormone levels and LH/FSH ratio in both groups. Patients with PCOS therapy have a tendency for normal body weight and reduction of severe obesity compared to patients without therapy. Clinical features such as regular menstrual cycle and the prevalence of acne and hirsutism are not significantly different between groups. Conclusion: PCOS cause irregularities of the menstrual cycle, the appearance of clinical manifestations, especially changes of LH/FSH ratio. Therapy for PCOS contributes to better regulation of endocrine and biochemical parameters, especially in the reduction of hyperinsulinemia, insulin resistance, and reduced LH/FSH ratio.


20 May 2021 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
MMMaja Mitrašinović-Brulić
Maja Mitrašinović-Brulić
ADAmela Dervisevic
Amela Dervisevic
AZAsija Začiragić
Asija Začiragić
MFMuhamed Fočak
Muhamed Fočak
AVAmina Valjevac
Amina Valjevac
DSDamir Suljević
Damir Suljević



5 January 2022 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
AFAlena Firdus
Alena Firdus
NANesina Avdagić
Nesina Avdagić
MFMuhamed Fočak
Muhamed Fočak
MMMaja Mitrašinović-Brulić
Maja Mitrašinović-Brulić
DSDamir Suljević
Damir Suljević